Drug Discovery - Medicine.net

PCSK9, statin combo may cut cholesterol post-transplant

Updated on: December 18,2025

PCSK9, statin combo may cut cholesterol post-transplant

Updated on:December 18,2025

Unlocking key insights into gene expression using a novel mouse model

Updated on: December 23,2025

Unlocking key insights into gene expression using a novel mouse model

Updated on:December 23,2025

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum

Updated on: February 04,2026

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum

Updated on:February 04,2026

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on: December 27,2025

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on:December 27,2025